Search

everythinglearnresearchcommunity

for

Search:↓

A new method accurately measures DHEAS in blood, improving on current tests.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

The humanized AA mouse model is better for testing new alopecia areata treatments.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Tofacitinib may help regrow hair in alopecia areata patients.

Targeting the AhR pathway may help treat alopecia areata.

The E413K mutation in the hHb6 gene causes monilethrix, a hair disorder, but doesn't show consistent symptoms.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

IL-15 promotes hair growth and protects hair follicles.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

HASHA is a safe and effective option for chin augmentation.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Diffuse lichen planopilaris greatly reduces quality of life.

Suppressing the HGPS mutation may improve symptoms and suggest reversibility.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Researchers found a new gene, hacl-1, that is active in mouse hair follicles during hair growth and may be important for hair biology.

The research found genes that may protect certain scalp cells from hair loss.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Researchers found a gene mutation responsible for a rare hair loss condition.

A 4kb fragment of the desmocollin 3 promoter targets gene expression to specific skin and hair follicle areas.

A woman with lupus had blood cell destruction, treated successfully with medication.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.